RP-L301
RP-L301-0124
Phase 2 mab on_hold
Quick answer
RP-L301 for Pyruvate Kinase Deficiency is a Phase 2 program (mab) at ROCKET PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ROCKET PHARMACEUTICALS, INC.
- Indication
- Pyruvate Kinase Deficiency
- Phase
- Phase 2
- Modality
- mab
- Status
- on_hold